Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- CheckyesterdayChange DetectedTwo new update dates (2026-04-02 and 2026-04-03) were added to the study record history, reflecting recent page updates.SummaryDifference0.1%

- Check8 days agoChange DetectedThe Study Record Dates were updated to include new entries dated 2026-03-27 and 2026-03-26, and to remove entries dated 2026-03-20 and 2026-03-19.SummaryDifference0.1%

- Check16 days agoChange DetectedAdditions indicate dates 2026-03-19 and 2026-03-20 with Revision: v3.5.0; deletions indicate dates 2026-03-12 and 2026-03-13 with Revision: v3.4.3.SummaryDifference0.1%

- Check23 days agoChange DetectedUpdates add 2026-03-12 and 2026-03-13 as new update timestamps and remove 2026-03-05 and 2026-03-06.SummaryDifference0.1%

- Check30 days agoChange DetectedNew release entries Revision: v3.4.3 added on 2026-03-06 and 2026-03-05, and older Revision: v3.4.2 entries dated 2026-02-27 and 2026-02-26 were removed.SummaryDifference0.1%

- Check37 days agoChange DetectedTwo recent update dates (2026-02-27 and 2026-02-26) were added to the study record history, and two earlier dates (2026-02-20 and 2026-02-19) were removed.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.